New Guideline Now Includes Implantable Tibial NeuroModulation (iTNM) Transitions Away from Step Therapy Requirement PARK CITY, Utah, April 29, 2024 /PRNewswire/ — BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of ReviTM, a patient-centric…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
